Compare CAG & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAG | TXG |
|---|---|---|
| Founded | 1919 | 2012 |
| Country | United States | United States |
| Employees | 26100 | N/A |
| Industry | Packaged Foods | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 6.0B |
| IPO Year | 1994 | 2019 |
| Metric | CAG | TXG |
|---|---|---|
| Price | $14.93 | $47.79 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 17 | 15 |
| Target Price | $16.88 | ★ $20.25 |
| AVG Volume (30 Days) | ★ 13.5M | 2.8M |
| Earning Date | 04-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 9.84% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,500,000,000.00 | $245,893,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $12.53 | $11.17 |
| 52 Week High | $20.32 | $50.34 |
| Indicator | CAG | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 53.59 | 64.44 |
| Support Level | $13.66 | $16.11 |
| Resistance Level | $16.07 | N/A |
| Average True Range (ATR) | 0.54 | 2.85 |
| MACD | -0.00 | -0.21 |
| Stochastic Oscillator | 54.29 | 71.64 |
Conagra Brands Inc is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). The majority of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company sells through the USA retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).